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Identification of the Amino Acid Subsets
Accounting for the Ligand Binding Specificity
of a Glutamate Receptor
Yoav Paas,* Miriam Eisenstein,† Franc¸ois Medevielle,‡ TMIV) and one membrane-embedded domain (MII) (Holl-
mann et al., 1994; Wo and Oswald, 1994, 1995; BennettVivian I. Teichberg,* and Anne Devillers-Thie´ry‡
and Dingledine, 1995).*Department of Neurobiology
Detailed amino acid sequence comparisons between†Department of Chemical Services
bacterial periplasmic binding proteins (PBPs) and mGluRsThe Weizmann Institute of Science
together with site-directed mutagenesis studies have es-76100 Rehovot
tablished that the amino-terminal domain (ATD)of mGluRsIsrael
forms a functional agonist-bindingsite with a three-dimen-‡Neurobiologie Mole´culaire
sional (3D) structure analogous to that of the leucine/iso-Unite´ de Recherche Associe´e D1284
leucine/valine-binding protein (LIVBP) (O’Hara et al., 1993).Centre National de la Recherche Scientifique
The PBPs are soluble proteins involved in the recogni-Institut Pasteur
tion and transport into the cell of amino acids, saccha-25 rue du Dr. Roux
rides, vitamins, and inorganic ions (Ames, 1986) and75015 Paris
which possess similar 3D structures (Quiocho, 1990;France
Kang et al. 1991; Oh et al., 1993, 1994) in spite of the fact
that their amino acid sequences may share no similarity.
Amino acid sequence alignments (Nakanishi et al.,Summary
1990; O’Hara et al., 1993) of iGluRs with PBPs have
suggested that the iGluRs are composedof twomodulesIn a situation so far unique among neurotransmitter
of PBPs, a LIVBP-like module at the amino terminus,receptors, glutamate receptors share amino acid se-
followed by a glutamine-binding protein (QBP) / lysine/quence similarities with the bacterial periplasmic bind-
arginine/ornithine-binding protein (LAOBP)-like moduleing proteins (PBPs). On the basis of the primary struc-
split into twodomains S1 and S2 (nomenclature of Stern-ture similarity of two bacterial periplasmic proteins
Bach et al., 1994) separated by the first three putative(lysine/arginine/ornithine- and phosphate-binding pro-
membrane-embedded segments. Since the PBPs areteins) with the chick cerebellar kainate-binding protein
all composed of two lobes with the ligand-binding site(KBP), a member of the ionotropic glutamate receptor
located in the interlobe cleft, it was proposed that thefamily, we have generated a three-dimensional model
two regions S1 and S2 of the QBP/LAOBP-like modulestructure of the KBP extracellular domain. By an inter-
of iGluRs are spatially organized like the PBPs creatingplay between homology modeling and site-directed
a specific ligand-binding site at their interface. Although
mutagenesis, we have investigated the kainate binding
support for this spatial organization was obtained from
properties of 55 different mutants (corresponding to
several studies (Kuryatov et al., 1994; Stern-Bach et al.,43 positions) and studied the interactions of some of
1994; Kuusinen et al., 1995), the specific amino acidthese mutants with various glutamatergic ligands. As
residues lining the Glu-binding pocket have not been
a result, we present here the subsets of amino acids
identified so far. Thus, an understanding of the microar-
accounting for the bindingfree energies and specificit-
chitectural motifs creating the ligand subtype specificity
ies of KBP for kainate, glutamate, and CNQX and pro-
of these Glu receptors is still missing.
pose a three-dimensional model, at the microarchi- To establish the structural basis of the pharmacologi-
tectural level, of the glutamatergic binding domain. cal specificity of a member of the family of the kainate
(KA) subtype of Glu receptors, we undertook a detailed
Introduction investigation of the ligand-binding domain of the chick
cerebellar KBP. This choice was motivated by the follow-
The membrane receptors mediating the effects of the ingfacts:KBP isa proteinwithhalf the size of KA receptors,
excitatory neurotransmitter glutamate (Glu) in the verte- but with thevery same pharmacologicalproperties (Gregor
brate central nervous system have been the subject, in et al., 1988); KBP possesses various mutually exclusive
recent years, of extensive research aimed at the charac- ligands that are likely to share a common binding site
terization of their structure and function. Molecular clon- (Gregor et al., 1988; Gorodinskyet al., 1993); and a DGKYG
ing of a large number of Glu receptors has established (residues 70–74) sequence, which is part of a GxGxxG
that they belong to two protein subfamilies distinguish- consensus nucleotide-binding motif (Hanks et al., 1988;
able by the presence of either seven or four putative Branden and Tooze, 1991; Bourne et al., 1991), has already
transmembrane (TM) domains. The metabotropic Glu been identified as forming part of the ligand-binding site
receptors (mGluRs) that act via G proteins belong to the of KBP (Paas and Teichberg, 1992; Paas et al., 1994), and
TM7 receptor subfamily (Pin and Duvoisin, 1995). The the role of residue Y73 in KA and GTP binding has been
other receptor subfamily includes the ionotropic Glu re- established (Paas et al., 1996).
ceptors (iGluRs) that function as ligand-gated channels Performing ligand binding measurements on 55 KBP
(reviewed by Gasic and Hollmann, 1992; Hollmann and mutants selected on the basisof the established structural
Heinemann, 1994) and the various kainate-binding pro- similarity of Glu receptors with PBPs, we have now identi-
teins (KBPs) (Gregor et al., 1989; Wada et al., 1989; Wo fied the subsets of amino acid residues forming, respec-
and Oswald, 1994), which are all supposed to harbor tively, the KA, Glu, and 6-cyano-7-nitroquinoxaline-2,3-
dione (CNQX) subsites within the ligand-binding domainthree membrane-spanning segments (TMI, TMIII, and
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of KBP. On the strength of these data, we propose here indicates that not all the residues contributing to the
binding have been identified, while a SDDG8 value highera 3D model structure of the KBP ligand-binding domain
than the DG8(WT) suggests that the interactions madethat fully accounts for the selectivity, competitive interac-
by the residues contributing to the SDDG8 value aretions, and binding energetics of the above mentioned KBP
necessary and possibly sufficient to account for theligands. This model can now serve as a template for the
ligand binding energetics. However, it is clearly possibleelaboration of parallel models of the ligand-binding do-
that additional residues are involved or that some resi-main of all Glu receptor channels.
dues interact only indirectly with the ligand and contrib-
ute to binding by stabilization of the ligand-binding
Results pocket via a hydrogen bond network (Berland et al.,
1995) or via the solvent.
Using this approach, we observed that the mutationsProbing the KBP Putative Ligand-Binding Domain
found to reduce the affinity for KA (E33V, Y36F, Y73I, andTo guide the selection of the KBP ligand-binding amino
T102A) did not fully account for KA binding free energy.acids to be mutated, we initially built a 3D model struc-
Moreover, the substitution of the other amino acids thatture based both on the X-ray structure of LAOBP (Oh
align with the ligand-binding residues of LAOBP (O’Haraet al., 1993) and on the amino acid sequence alignment
et al., 1993) and that were predicted to contribute to KAof KBP with LAOBP as proposed by O’Hara et al. (1993).
binding were found either to not affect KA binding (T30AWe then mutated by site-directed mutagenesis the
and L263A) or to completely abolish it (R107S, T268A, andamino acid residues aligning with the ligand-binding
E316A/Q). In the lattercase, the transfected cell membraneresidues of LAOBP. We also mutated the residues lo-
preparations were also submitted to SDS–polyacrylamidecated in the interlobe cleft (i.e., in the putative ligand-
gel electrophoresis (SDS–PAGE) to allow the probing, withbinding pocket) and in its vicinity. Furthermore, we mu-
anti-KBP antibodies, of the presence and integrity of KBPtated residues in the glycine-rich motif (G69–G74, which
(see below).include the GxGxxG nucleotide-binding motif) as well
On the strength of these results and assuming thatas those amino acids present in the KBP segment W82–
R107, T268, and E316 were not involved in ligand bind-Q92 that has no counterpart in LAOBP according to
ing, we reasoned that the reliance on the LAOBP tem-O’Hara et al. (1993). Finally, we mutated residues in
plate for KBP modeling had to be challenged. In thesegment K276–K297 that do not align well with LAOBP.
search for an alternative and guided by the approachIn most cases, residues were substituted with alanine,
described in detail in the Experimental Procedures (un-but specific amino acid substitutions were also made
der the headingAlignments and Computer-Assisted Mo-to produce more limited reductions of either charge,
lecular Modeling), we observed that the atomic coordi-hydrogen bonding capacity, or bulkiness.
nates of two PBPs, the LAOBP (Oh et al., 1993) and theFollowing transfection of human embryonic kidney
phosphate-binding protein (PhosBP; Luecke and Quio-(HEK) 293 cells with the various plasmids harboring the
cho, 1990; Wang et al., 1994), were likely to provide moremutated KBP cDNAs, we carried out measurements of
appropriate templates for building a model structure of
the displacement by unlabeled KA of [3H]KA bound to
KBP. This model structure includes two lobes, I and II,
purified membrane preparations and determined the
built according to the atomic coordinates of LAOBP and
values of the apparent dissociation constant for inhibi-
PhosBP, respectively. It also suggests a novel sequence
tion, Ki(KA), for all mutants. For the mutants found to alignment between KBP and PBPs (Figure 1) that differs
affect KA binding, the respective DG8 values were then from the three alignments proposed (Nakanishi et al.,
calculated from the relation: DG8 5 2RT lnKiapp. 1990; Cockcroft et al., 1993; O’Hara et al., 1993). Upon
The DG8 values of the Gibbs free energy of binding inspection of the interlobe cleft of this KBPhybrid model
were used in the following way to help us in the assess- structure, several predictions were made. Accordingly,
ment of whether all the amino acids that contribute to the we performed a second round of mutations and ob-
binding of a given ligand have been identified. Assuming served that, indeed as expected, mutants displaying
that the mutation does not modify the conformation of the substitutions S266A, S267A, and Y299A exhibited a
the ligand-binding domain, we reasoned here that a decreased affinity toward KA.
mutation in the binding site will primarily affect the ability In Table 1, we present the KA binding parameters of
of the replacing residue to interact directly with the li- all the KBP mutants. Calculating the SDDG8 value for
gand, but may also perturb the short distance interac- the set of mutations displaying a reduced affinity for KA
tions made upon ligand binding by the given residuewith (see Table 3), one observes that it is in excess of the
its neighbors. Bysubtracting the value DG8 measured for DG8 for WT KBP. Thus, on the basis of this criterion, we
the mutant from that obtained for wild-type (WT) KBP, concluded that most if not all the amino acids involved
a value DDG8 is obtained. The latter represents the con- in KA binding have been identified. Since the predictions
tribution of the substituted side chain to the ligand bind- of the KBP hybrid model turned out to be correct for
ing energy. It will be underestimated if the replacing KA binding, we used it as well for the identification of
residue at the mutated position contributes, by itself, to the subset of amino acids accounting for the binding of
the ligand binding free energy. It will be overestimated Glu and CNQX (Table 2), focusing mainly on the muta-
if the substituting residue itself, while not being in direct tions displaying a reduced KA affinity.
contact with the ligand, weakens binding by affecting
its neighbors in the ligand-binding pocket. Adding the Identification of the Amino Acids Lining
DDG8 values for all the mutations affecting the binding the Ligand-Binding Pocket
of a given ligand, one obtains a value designated as On the basis of the results obtained from 55 mutants
corresponding to 43 different locations, four classes ofSDDG8. A condition in which SDDG8 < DG8(WT) clearly
Probing the Ligand-Binding Pocket of a Glu Receptor
981
Figure 1. Multiple Alignment of Bacterial
PBPs with Selected KBPs and iGluRs
The sequences of LAOBP and PhosBP were
taken from X-ray structures (Oh et al., 1993;
Luecke and Quiocho, 1990). For definition of
segments S91 and S92, see legend to Figures
4A and 4B. cKBP and fKBP correspond to
proteins from chick cerebellum and frog
brain, respectively. LAOBP and PhosBP can-
not be aligned by standard alignment pro-
grams and were therefore aligned on the ba-
sis of their X-ray structures. The structural
alignment was performed separately for lobe
I (LAOBP residues 1–88 plus 196–232) and
lobe II (LAOBP residues 89–195) by superim-
posing the Ca atoms of corresponding sec-
ondary structure elements that are denoted
here by the underlined residues. The root
square mean deviation (rsmd) for 84 Ca
atoms in the upper lobe is 2.9 A˚, and the rsmd
for 47 Ca atoms in the lower lobe is 2.5 A˚. The
alignment of cKBP with LAOBP and PhosBP
was carried out as described in the Experi-
mental Procedures. QBP, fKBP, GluR1,
GluR5, and GluR6 were aligned with KBP us-
ing FASTA. Except for the PhosBP N177 and
LAOBP Q143 (see below), the bold residues
correspond to amino acids shown to be either
in contact with the ligand (LAOBP and
PhosBP) or to be involved in ligand binding
(cKBP, GluR1 [Paas et al., 1996; Mano et al.,
1996]). The PhosBP N177 and LAOBP Q143
residues were shown to be located within the
ligand-binding pocket and to contribute to its
bond network via PhosBP T10 andT141 and
LAOBP Y14, respectively.
mutations were defined: mutations that reduced the by the mutation of one of the amino acids involved in
the binding of KA and Glu. Indeed, Y73 appears to playKBP affinity for a ligand by at least a factor of five (Figure
2; bold letters in Tables 1 and 2); mutations that caused a pivotal role in ligand recognition as it is involved in
the binding not only of all three ligands, but also of GTPpartial or total degradation of KBP and a subsequent
loss of KA binding (Figure 3 and Table 1); mutations that (Paas et al., 1996). In contrast, replacement of P100 for
an alanine resulted in a significant loss of binding affinitycaused no degradation of KBP but a complete loss of
KA binding (Figure 3 and Table 1); mutations that pro- for CNQX, a small effect on Glu binding, and no effect
on KA binding.duced no changes in the KBP affinity for KA, Glu, or
CNQX (Tables 1 and 2). According to the results presented in Table 3, the
amino acid residues forming the KA- and Glu-bindingMutations That Significantly Reduced the KBP Affinity
for at Least One Ligand sites seem to have been identified, but not all those
forming the CNQX-binding site. In the latter case, weTables 1 and 2 and Figure 2 show that only eight amino
acid residues of the 43 positions examined are involved investigated all the KBP mutants harboring mutations
of residues predicted to be in the ligand-binding pocketin ligand binding: E33, Y36, Y73, P100, T102, S266, S267,
and Y299. Their involvement is ligand selective as ex- and displaying KA binding. This included mutations of
W82, L101, and T30 located in thevicinity of the interlobepected from residues forming a binding pocket able to
recognize ligands with very different chemical struc- cleft. Although the apparent Ki value for CNQX could
not be determined from the displacement curve ob-tures. The sets of amino acids involved in binding not
only differ for each ligand, but also in the extent of their served for Y73I (Figure 2 and Table 2), the contribution
of this tyrosine side chain to the CNQX binding freeinvolvement. Substitution of E33 for valine exerts a very
strong effect (110-fold decrease) solely on KA binding. energy can be estimated to be larger than 4 kcal/mol.
Inspection of the data presented in Figure 2 and TableIn contrast, the decrease in binding affinity for Glu is
much more profound than for KA in the case of Y36F 1 shows that the displacement curves for KA binding
display Hill coefficient (nH) values significantly greater(30- and 5-fold, respectively), Y73I (90- and 10-fold, re-
spectively), and T102A (100- and 58-fold, respectively). than 1.0 but smaller than 2.0, indicating that KA binds,
in a cooperative manner, to two subunits of the membra-The moderate but statistically very significant effect on
the KA binding affinity revealed in the case of S266A, nous KBP complex. Interestingly, the E33V, T102A,
S266A, and S267A mutants exhibit approximately theS267A, and Y299A (5- to 6-fold decrease) is not ob-
served for Glu binding. CNQX binding is affected only same nH values as WT KBP, while Y36F, Y73I, and Y299A
Neuron
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Table 1. Apparent Ki Values in mM (mean 6 SD) and Hill Coefficients (nH 6 SD) for KA Binding to WT KBP and Its Mutants
Lobe I Lobe II
Mutation Ki Value Hill Coefficient Mutation Ki Value Hill Coefficient
*T30A WT *L263A WT
*E33V 50.6 6 16.4 1.4 6 0.1 *L263T WTa
Y36A NB G265N NB
Y36I NB S266A 2.5 6 0.8 1.4 6 0.1
Y36F 2.3 6 0.3 1.8 6 0.1 S267A 2.3 6 0.3 1.6 6 0.1
D70S NB *T268A NB
D70N WTa Y270F WT
K72A WT V283A WT
K72T WT Y284A WT
Y73I 4.8 6 0.9 1.9 6 0.1 Y284I WT
S79V WT E285A WT
W82A WT Y286I WT
T83A NB M287A NB
G84A NB M287V WT
M85A WT D288A WT
I86A WT D288S WT
G87R WT K289S WT
E88V WT R290S WT
I89A WT R291S WT
L90A NB V294A NB
L90V WT V294I WTa
*P100A WT L295A WT
L101A NB K297T WT
L101V WT Y299A 2.6 6 0.5 1.9 6 0.1
*T102A 26.2 6 7.7 1.4 6 0.1 *E316A NB
*R107S NB *E316Q NB
S317A WT
F342I NB
G343A WT
The apparent Ki value for WT KBP is 0.45 6 0.05 mM and its nH 5 1.50 6 0.1. Asterisks indicate the residues aligning, according to O’Hara
et al. (1993), with the ligand-binding residues of LAOBP. The mutants in bold correspond to residues likely to be involved in KA binding. Their
apparent KA binding affinity significantly differs from that of the WT KBP (p , 0.015). Y36F, Y73I, and Y299A display significantly different
Hill coefficient value compared with WT KBP (p , 0.025). All values were rounded to the closest decimal number.
WT indicates that the mutant KBP binds the ligand with the same affinity as WT KBP or with slightly decreased apparent affinity, up to
2-fold. WTa represents the cases in which the apparent affinity decreased up to 3-fold.
NB represents the mutants that showed no [3H]KA binding. The expressed level and integrity of the KBP mutants as probed with anti-KBP
antibodies are shown in Figure 3.
mutants display significantly higher values. In allosteric place, and the mutated KBP binds ligands with approxi-
mately the same affinity as the WT KBP (Figure 3 andproteins, a change of the nH due for instance to a muta-
tion indicates a loss or gain of intersubunit interaction Table 1).
Mutations That Caused No Degradation of KBPenergy. In the case of two identical binding sites, the
free energy of intersubunit interactions (DG8H) can be but a Complete Loss of KA Binding
The pattern of migration on SDS–polyacrylamide gelscalculated from the relation DG8H 5 1⁄2RT ln[(2 2 nH)/nH]
(Wyman, 1964; Levitzki, 1978). Subtraction of the DG8H of the Y36I, R107S, T268A, V294A, E316Q, and F342I
mutants is also presented in Figure 3 because they be-values calculated for the KBP mutants from that of WT
KBP yields a DDG8H value (see footnotes to Table 3). long to a group of mutants that migrate as the WT KBP,
but display no detectable KA binding affinity (see TableThe latter represents the gain or loss of energy of inter-
subunit interactions. The DDG8H values are small but 1). This lack of binding is not due to a low level of
expression of the mutated proteins. The intensity of thesignificant and may account for part of the loss of ligand
binding free energy (DDG8) displayed by Y36F, Y73I, and immunolabeling of the KBP mutants is equal to or
stronger than that of WT KBP (Figure 3). Therefore, onepossibly by Y299A. Notably, CNQX binding to WT KBP
and its P100A mutant display no cooperativity (nH 5 1.0) cannot conclude as to the role in ligand binding of the
residues R107, T268, E316, and F342 though, as de-as expected from an antagonist.
Mutations That Caused Partial or Total Degradation scribed below, they are located in the vicinity of the
predicted ligand-binding pocket.of KBP and Subsequent Loss of KA Binding
Figure 3 presentsdata illustrating the finding that several Mutations That Produced No Significant Changes
in KBP Affinity for KA, Glu, and CNQXmutations lead to partial or total degradation of KBP.
These include Y36A, D70S, T83A, G84A, L90A, L101A, Of the 43 different locations at which amino acid substi-
tution were made, 29 had no influence on ligand binding.G265N, M287A, and E316A. However, when more con-
servative mutations aremade at some of these positions Mutations as drastic as G87R, E88V, or E285A did not
affect KA, Glu, or CNQX binding, indicating that the(D70N, L90V, L101V, and M287V), no degradation takes
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currents align with the ligand-binding residues ofTable 2. Apparent Ki Values (mean 6 SD) and Hill Coefficients
(nH 6 SD) for Glu and CNQX Binding to WT KBP and Its LAOBP. Stern-Bach et al. (1994) performed electrophys-
Mutants Carrying Mutations of Residues Located in the iological recordings and ligand binding measurements
Predicted KA-Binding Pocket and Its Vicinity on KA/AMPA receptor chimeras and provided an ele-
gant demonstration that the S1 and S2 segments deter-KBP Mutant
(or WT) Glu (mM) nH CNQX (mM) nH mine the pharmacological specificities of iGluRs. How-
ever, this study as well as that of Kuusinen et al. (1995),WT KBP 30 6 3 1.2 6 0.1 0.8 6 0.1 1.0 6 0.1
who produced a soluble Glu/AMPA-binding domain, did*T30A WT WT
*E33V WT WT not shed light on the specific amino acids directly in-
Y36F 924 6 155 1.8 6 0.1 WT volved in binding of Glu, KA, or AMPA.
Y73I 2694 6 713 1.8 6 0.1 NC Kuryatov et al. (1994), Wafford et al. (1995), and Hirai
W82A WTa WTa
et al. (1996) also used the methodology of site-directed*P100A WTa 8.0 6 2.3 1.0 6 0.1
mutagenesis followed by electrophysiological record-L101V WT WT
ings to reveal the amino acids of the NMDA R1 subunit*T102A 3060 6 1167 1.0 6 0.1 WT
S266A WT WT involved in glycine and/or Glu activation. The mutated
S267A WT WT residues affecting the efficacy of glycine as a coagonist
Y299A WT WT were found to beat positions equivalent to those forming
The mutants in bold correspond to residues likely to be involved in the ligand-binding site of LAOBP. It remains possible,
Glu or CNQX binding. Their Glu or CNQX binding affinity is signifi- however, that some mutations produced allosteric ef-
cantly different from that of WT KBP (p , 0.015). Y36F and Y73I fects, since the response properties of Glu were also
display significantly different nH values compared with WT KBP affected, albeit to a lesser extent. Thus, not all the identi-
(p , 0.002). All values were rounded to the closest decimal number.
fied amino acids may directly interact with glycine. In thisAsterisks, WT, and WTa are as in Table 1.
respect, inspection of the KBP hybrid model structureNC indicates that the apparent Ki value could not be calculated
because of the lack of CNQX solubility at concentrations $0.5 mM suggests that a small ligand such as glycine is unlikely
(see Figure 2C). to be in concurrent contact with all the residues sug-
gested by Kuryatov et al. (1994) and Hirai et al. (1996).
It is of importance to point out that the results of ligand
disruption of localnetworks of interactions did not cause
binding measurements performed in the present studydistant detrimental effects.
on mutant receptor proteins at equilibrium, and the sub-
sequent calculations of the binding free energies andDiscussion
their sums (SDDG8), are not on their own devoid of ambi-
guities of interpretation. The reasons for this are as fol-
The notion according to which the ATD and the TMIII–
lows: a mutation of a ligand-binding residue may affectTMIV-connecting segment of iGluRs form an extracellular
the network of mutual interactions between residues inligand-binding domain shaped like the bilobated bacterial
the ligand-binding pocket (Schreiber and Fersht, 1995)PBPs (O’Hara et al., 1993) has already been supported by
and may subsequently affect ligand binding indirectlystudies showing that both segments contribute to the
as well; the substituting side chain might weaken ligandpharmacological specificities of iGluRs (Kuryatov et al.,
binding, while not being in direct contact with the ligand;1994; Stern-Bach et al., 1994; Kuusinen et al., 1995; Hirai
mutations affecting the ligand-binding residues cannotet al., 1996). However, no descriptionof the ligand-binding
be readily distinguished from those of residues involvedpocket of a Glu receptor was made until now to account
in the maintenance of the conformation of the entireindetail for its pharmacological specificities. In the present
ligand-binding domain. These various side effects (men-study, we have identified, in the chick cerebellar KA-bind-
tioned above) may cause the SDDG8 to exceed signifi-ing protein, a member of the KA/AMPA (a-amino-3-
cantly the DG8 value of KA binding to WT KBP. Thus,hydroxy-5-methyl-4-isoxazole-propionic acid) receptor
the SDDG8 value should be seen only as an assistingfamily, the aminoacid residues formingthe sitesof interac-
tool. It cannot be used exclusively to decide on thetions of KA, Glu, and CNQX. This identification was ren-
nature and number of amino acid residues involved indered possible by the methodology adopted here that
binding. Information on the high affinity desensitizedcombines site-directed mutagenesis, ligand binding mea-
state of the receptor is obtained when ligand bindingsurements, free energy determinations, and computer-as-
studies are performed at equilibrium. Thus, only aminosisted molecular modeling.
acids contributing to high affinity ligand binding may bePrevious studies on non-NMDA (N-methyl-D-aspar-
identified, while those involved exclusively in the lowtate) receptors have used only some of the components
affinity active state may not be identified.of this methodology and, thus, did not reach the present
The ambiguities of mutagenesis followed by ligandlevel of resolution. Uchino et al. (1992), Li et al. (1995),
binding studies are nevertheless counterbalanced in theand Mano et al. (1996) have mutated residues in the
present case by the availability of the already resolvedputative extracellular portions of AMPA receptors and,
protein structures of LAOBP and PhosBP that can beby using electrophysiological recordings from Xenopus
used as templates for KBP model building. Accordingly,oocytes, observed changes in the agonist efficacy of
the proposed model structure can beexamined todeter-Glu, AMPA, and quisqualate (Quis) but not of KA. Whether
mine whether the amino acids identified as forming athe mutations affected ligand bindingrather than the chan-
specific ligand-binding site are found at spatial locationsnel activation pathway could not be unequivocally distin-
compatible with the chemical structure and space-fillingguished. However, in Mano et al. (1996), the residues af-
fecting the ability of Quis and Glu to inhibit KA-evoked properties of the ligand. Although a model structure
Neuron
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Figure 2. Mutations Affecting Ligand Binding to KBP
Inhibition of the binding of [3H]KA to membrane-bound WT KBP (open circles) and its mutants (closed circles) by KA (A), Glu (B), and CNQX
(C). The substituted amino acids, their positions, and the replacing residues are indicated within the small figures. Error bars represent the
standard deviation for at least two experiments performed in triplicates. The binding parameters are detailed in Tables 1 and 2.
remains only an approximation of the real structure, it by the location outside the interlobe cleft, of the many
residues that were found not to be involved in ligandis of heuristic value if the suggested structure is coher-
ent and in agreement with the experimental results. binding (green balls in Figure 4; see below). Inspection of
the results presented in Figure 2 and Tables 1–3 readily
reveal that the residues involved in ligand binding areThe Ligand-Binding Pocket
The boundaries of the ligand-binding pocket are de- mainly those that were predicted to be in the ligand-
binding pocket from both the sequence similarity be-fined, from a biochemical point of view, by the amino
acid residues for which mutations affect ligand binding. tween KBP and bacterial PBPs (see Figure 1) and from
the model structure based on the established X-rayThey are also delineated, on the basis of the KBP model,
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Figure 3. Immunoblot of Membrane-Bound
WT KBP and a Few of Its Mutants
HEK 293cells were transfected with an empty
pMT3 plasmid (sham) or with a pMT3 plasmid
harboring cDNAs encoding WT KBP or its
mutants. Following membrane preparation,
aliquots of 40 mg proteins were subjected to
analysis by SDS–PAGE followed by immu-
noblotting with affinity-purified polyclonal
anti-KBP antibodies. The WT KBP is seen as
a 49 kDa polypeptide and corresponds to a
preparation expressing 300 pmol KBP/mg
protein. Note that the crude membrane prep-
arations possibly contain ER- and Golgi
membrane-bound KBP. However, when WT
KBP or its mutants that display the same KA
binding affinity were expressed, there was a
linear correlation between the ECL signal and
the level of [3H]KA binding. The substituted
amino acids, their positions, and the replac-
ing residues are indicated within the figure.
The KBP mutants T83A and G84A with which several transfections were made were not detected by the specific antibodies. We assume that
the T83A and G84A mutants underwent complete degradation, since the cells transfected with these two mutants displayed the typical
morphological changes of high KBP expression (round and poorly adhering cells).
structures of two PBPs (Figure 4). Particularly in lobe I, addition, Y299 aligns with the PhosBP N177 residue
that is located within the phosphate-binding pocket andthe ligand-binding residues of KBP share with those of
bacterial PBPs similar side chain properties. In all iGluR contributes to the bond network that stabilizes it. None
of the ligand-binding residues is positively charged, butsubunits, the aromaticity at positions equivalent to the
Glu/KA-binding residues of KBP, Y36, and Y73 is con- all of them, except for P100, have the ability to form
hydrogen bonds. Such a mode of ligand binding, basedserved. The same applies to the hydroxyl moiety of T102,
except in the case of GluR6, that harbors an alanine on hydrogen bonding rather than ionic pairing, is surpris-
ing in view of the fact that KBP binds preferentiallyat the equivalent position. E33 that was shown, upon
mutagenesis, to affect KA but not Glu binding affinity is dicarboxylic amino acids such as KA, domoate, and Glu.
conserved in all non-NMDA receptors. S267 is con-
served in most of the iGluRs. The KBP ligand-binding Amino Acids Likely to Contribute to the
Stabilization of the Tertiary Structurepocket includes Y299, which is not conserved. It is note-
worthy that the AMPA and KA ionotropic receptors con- The KBP hybrid model structure places the side chains
of R107, T268, E316, and F342 in the vicinity of thetain, at the equivalent position, a hydroxyl moiety. In
Table 3. Ligand Binding Energetics of WT KBP and Its Mutants
KA Glu CNQX
KBP WT or Mutant DG8 DDG8 DDG89 DG8 DDG8 DDG89 DG8 DDG8
E33V 5.4 6 0.2 2.6 6 0.2 2.7 6 0.2 WT 0 0 WT 0
Y36F 7.1 6 0.1 0.9 6 0.1 0.6 6 0.2a 3.8 6 0.1 1.9 6 0.1 1.3 6 0.2b WT 0
Y73I 6.7 6 0.1 1.3 6 0.1 0.7 6 0.3a 3.2 6 0.2 2.5 6 0.2 2.0 6 0.2a NC NC
P100A WT 0 0 WT 0 0 6.5 6 0.2 1.2 6 0.2
T102A 5.8 6 0.2 2.2 6 0.2 2.3 6 0.2 3.2 6 0.3 2.5 6 0.3 2.6 6 0.3 WT 0
S266A 7.1 6 0.2 0.9 6 0.2 1.0 6 0.2 WT 0 0 WT 0
S267A 7.1 6 0.1 0.9 6 0.1 0.8 6 0.1 WT 0 0 WT 0
Y299A 7.1 6 0.1 0.9 6 0.1 0.6 6 0.3c WT 0 0 WT 0
WT KBP 8.0 6 0.1 0 0 5.7 6 0.1 0 0 7.7 6 0.1 0
SDDG8 9.7 6 0.4 6.9 6 0.4 NC
SDDG89 8.7 6 0.6 5.9 6 0.4
WT and NC are as in Table 2.
Gibbs free energies DG8 in kcal/mol, are calculated as described in Experimental Procedures.
DDG8 5 DG8(WT)2DG8(mut).
The calculated DDG89 value is the net free energy of binding and accounts for the fact that DDG8 includes the gain or loss of energy of
intersubunit interactions (DDG8H). Thus, DDG89 5 DDG82DDG8H where DDG8H 5 DG8H(WT)2DG8H(mut) and DG8H 5 10.5 RT ln[(22nH)/nH], nH being
the Hill coefficient value. For example, for WT KBP, nH 5 1.5, thus, DG8H(WT) 5 0.5 3 RT 3 ln[(221.5)/1.5] 5 20.3 kcal/mol. The negative value
indicates that energy ought to be invested to allow the intersubunit allosteric transition. For Y73I, the intersubunit interaction energy is
DG8H(Y73I) 5 0.5 3 RT 3 ln[(221.93)/1.93] 5 20.9 kcal/mol, thus DDG8H(Y73I) 5 20.3 kcal/mol 2 20.9 kcal mol 5 10.6 kcal/mol. DDG89(Y73I) 5 1.3
kcal/mol 2 0.6 kcal/mol 5 0.7 kcal/mol.
All values were rounded to the closest decimal number. However, the nonrounded figures were used for the statistical analysis. DG8(mut) versus
DG8(WT): p , 0.0015. DDG8 versus DDG89: a p , 0.05; b p , 0.01; and c p , 0.11. SDDG8 versus SDDG89 for KA and Glu binding was p , 0.045
and p , 0.035, respectively.
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Figure 4. The KBP Hybrid Model Structure
(A) Transmembrane topology of KBP. Segment S1 (amino acids 1–147) represents the stretch extending from the first amino acid to TMI,
while S2 (residues 232–397) is composed of the amino acid sequence connecting TMIII to TMIV. Segments S91 (residues 24–129) and S92
(residues 245–377), which constitute the model structure and harbor the ligand-binding pocket, are shown in cyan and blue, respectively. The
white stretches show the KBP segments that were not accounted for in the model of KBP (Figure 4B). In a previous unpublished work, a KBP
mutant lacking the amino-terminal first 10 amino acids was shown to bind KA as efficiently as WT KBP.
(B) The bilobated model structure of the ligand-binding domain of KBP. Segment S91, beginning at residue 24 (cyan ball), is depicted in cyan
color, whereas segment S92 is shown in blue. Lobe I is built of S91 residues 24–119 and of S92 residues 341–377. Lobe II is composed of S91
residues 120–129 and S92 residues 245–340. The amino acids likely to interact with KA, Glu, and CNQX and thus to line the binding pocket
are shown in yellow. These are E33, Y36, Y73, T102, S266, S267, and Y299 for KA; Y36, Y73, and T102 for Glu; Y73 and P100 for CNQX; and
Y73 and K72 for GTP (Paas et al., 1996). The amino acid residues likely to be involved in stabilization of the protein tertiary structure are
shown as magenta-colored balls. The amino acids shown not to be involved in ligand binding are presented as green balls. The white loop
(segment G69–N81 of lobe I) is a region having no counterpart in LAOBP. It was built as described in Experimental Procedures. The blue ball
at position 276 shows the beginning of the loop–a helix–loop–b strand structure (amino acids 276–297; for details, see Experimental Procedures).
(C) The suggested docking mode for KA. E33 forms a hydrogen bond with the tertiary amino group of the KA ring, Y73, T102, and S267 form
hydrogen bonds with the oxygen atoms of the KA 3-carboxymethyl moiety, while the hydroxyl groups of S266 and Y299 form hydrogen bonds
with the KA 2-carboxyl moiety. The interaction between T268 and Y299 is equivalent to that formed in PhosBP by N177 and T141.
(D) Two docking modes for Glu are illustrated. Glu a-carboxyl is predicted to serve as a hydrogen bond acceptor for the hydroxyl group of
either Y73 or T102, while its a-amino group interacts with the hydroxyl group of either T102 or Y73. Alternatively, a p-cation interaction
between the amino group of Glu and the aromatic ring of Y73 may take place. According to both docking patterns, the Glu g-carboxyl moiety
is suggested to serve as a hydrogen bond acceptor for the hydroxyl group of Y36.
(E) Suggested docking mode of CNQX. The dashed white lines represent the possible hydrogen bonds. The ligands are shown with the
following color code: carbon, green; oxygen, red; nitrogen, blue. The protein residues are colored as described in (B).
ligand-binding pocket. Yet, the R107S, T268A, E316Q, stabilizing the conformation of the ligand-binding poc-
ket. We favor the latter possibility, because the KBPand F342I mutants did not display any KA binding
though they were expressed in HEK 293 cells to very model structure shows that R107, E316, and F342 are
too far away to be in direct contact with KA, while T268high levels and migrated on SDS–PAGE as WT KBP
(Figure 3). Thus, the role of these residues in ligand is closer but more likely to interact with S266 and Y299
(Figure 4C). It is relevant to mention that the amino acidsbinding cannot be established, since either the residues
R107, T268, E316, and F342 interact directly and in a that belong to this category are highly conserved
throughout the iGluRs and KBPs.critical fashion with KA or/and play a structural role in
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KBP as an Allosteric Protein may account for the guanine nucleotide binding proper-
ties of KBP (Paas and Teichberg, 1992; Paas et al., 1994,The Hill coefficient values for the displacement curves
of KA observed for WT KBP and its mutants (Table 1) 1996; Gorodinsky et al., 1993). Second, the KBPGxGxxG
nucleotide binding address or glycine-rich motif (resi-clearly indicate the existenceof cooperative interactions
between two homologous binding sites in the membra- dues 69–74) is located at the opening of the interlobe
cleft at an exposed position readily available for interac-nous KBP complex. The larger nH values displayed by
the Y36F, Y73I, and Y299A mutants for KA binding and tions with antibodies. This is in line with the observations
that antibodies directed against the KBP nucleotideby Y36F and Y73I mutants for Glu binding (Table 2) are
at first glance quite puzzling. However, a change in nH binding address prevent the photoaffinity-labeling reac-
tion of GTP with KBP (Paas et al., 1996). Third, the KBPis expected in allosteric proteins if the transition to the
high affinity state is impaired by a mutation that affects region corresponding to the flip-flop region of AMPA
receptors (Sommer et al., 1990) is not located in theeither the interconversion between states or the ability
of the ligand to stabilize the high affinity state. In the case vicinity of the interlobe cleft but rather forms a long
kinked a-helical structure at the back of the molecule.of KBP, as it is for many neurotransmitter receptors, the
ligand stabilizes the transition to the high affinity state It is depicted, in Figure 4B, as part of the dark blue
segment in lobe I. It is of interest to note that mutationsand thus the latter is likely to be affected by the mutation
of a residue participating in ligand binding. Accordingly, introduced in AMPA receptors at positions correspond-
ing to the residues located close to the kink of this longthe calculated DDG8 values for the Y36F and Y73I will
include a contribution to the allosteric transition, i.e., helix were shown by Partin et al. (1995) to exert an
influence on the sensitivity of GluR1 toward cyclothia-to the intersubunit interaction energy (Wyman, 1964;
Levitzki, 1978). In the case of Y299A, no statistically zide, an agent that interferes with the desensitization
process of AMPA receptors. Fourth, the residues thatsignificant difference exists between DDG8 and DDG89
(see Table 3). do not affect ligand binding (green balls in Figure 4) are
located away from the ligand-binding site.In view of the homology of KBP with LAOBP, it is of
relevance to mention that the latter exists, in the absence Most recently, Sutcliffe et al. (1996) have proposed a
model structure of theAMPA GluR1-binding domain andof ligand, in a dynamic equilibrium of two conformations
with open and closed lobes. Upon ligand binding, the a mode for KA docking in GluR6 based solely on the
homology with LAOBP and on the mutations previouslyclosed conformation of LAOBP is being stabilized (Oh et
al., 1993). If such stabilization of a closed-lobe conforma- introduced, in GluR1, at two positions (E398 and K445)
by Uchino et al. (1992) and Li et al. (1995). The proposedtion also takes place in a KBP subunit upon binding of an
agonist, one may expect that the closed conformation of location of K445 in the ligand-binding pocket as pro-
posed by Sutcliffe et al. (1996) is neither in line with ourthe neighboring subunit will be stabilized as well. Thus,
mutations of some of the residues in the ligand-binding binding data nor with the results of Mano et al. (1996
and unpublished data) who did not observe changespocket are anticipated to affect the ability of the ligand to
bind and regulate the allosteric transitions. Accordingly, in KA-, Glu-, and Quis-evoked responses in Xenopus
oocytes injected with the GluR1 K445A mutant.one may suggest that, among the ligand-binding residues,
Y36 and Y73 contribute to the allosteric properties of KBP,
while E33, T102, S266, and S267 do not.
The Specific Ligand-Binding Sites
KA interacts with all the amino acids forming the KBP
ligand-binding pocket with the exception of P100. FourA Model Structure of the Ligand-Binding Domain
The current KBP hybrid model structure of the ligand- residues belong to the S1 region and three to the S2
region (see Figure 4A for definition and amino acid num-binding domain of KBP (Figure 4A) depicts almost the
entire KBP with the exception of the putative TM seg- bering), indicating that the KA-binding domain occupies
the interface between the two regions. However, analy-ments, the TMI–TMIII-connecting stretch, and the intra-
cellularly located carboxy-terminal tail of 47 amino sis of the contributions to the free energy of KA binding
of the individual amino acid residues shows a signifi-acids. Thus, the model includes most of the extracellu-
larly located regions of the protein, but lacks the 18-, cantly larger contribution to binding of the S1 residues
(7 kcal/mol) than of the S2 residues (2.7 kcal/mol). The13-, and 20-amino acid long extracellular segments that
are respectively located adjacent to TMI, TMIII, and suggested docking modes of KA is presented in Figure
4C. It is in line with thespace-filling and chemical proper-TMIV and that have no counterparts in the PBPs. Since
segments of 13–20 amino acids can be of significant ties of KA.
Glu interacts with three of the amino acids lining thelengths, depending on their conformation, one cannot
decide, as other authors did (Stern-Bach et al., 1994; KA-binding pocket and may bind in two docking modes,
as illustrated in Figure 4D. It is of importance to noteSutcliffe et al., 1996; Hirai et al., 1996), as to the parallel,
perpendicular, or oblique orientation of the lobes with that the lobe II residues that line the ligand-binding
pocket and interact with KA do not interact with Glu.respect to the plane of the membrane.
Inspection of the model structure reveals several Notably, to optimize hydrogen bonding, T102 must
have different side chain conformations when KA or Gluprominent structural features. First, in both lobes, a cen-
tral core of a pleated sheet is found surrounded by are docked within the binding pocket. In view of the
homology of KBP with LAOBP, it is of relevance to men-helices. This supersecondary structure, called the Ross-
mann fold (Branden and Tooze, 1991), is typical not only tion that upon lysine binding to LAOBP, three side
chains, located within the substrate binding pocket,of PBPs but also of nucleotide-binding proteins, which
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NotI and XhoI sites. Mutants were constructed by PCR with thechange their position in respect to the backbone (Figure
mutagenic oligonucleotides chosen so as to introduce a new restric-4b of Oh et al., 1993).
tion site to be used for screening. For those putative mutants withAmong the residues affecting KA binding, only Y73I
the expected restriction map, the sequence was verified using the
interacts with CNQX. The search among all the residues T7 sequencing kit from Pharmacia as recommended.
located in the predicted ligand-binding pocket for addi-
tional interacting residues led, following inspection of Membrane Preparations and Binding Assays
the KBP hybrid model structure, to the examination of Transfections of adhesive HEK 293 cells were performed as de-
scribed by Paas et al. (1996). For the assay of [3H]KA binding tothe P100A mutant. The latter was found, indeed, to lose
membrane-bound WT KBP and its mutants, the protocols describedaffinity toward CNQX. In light of the fact that none of
by Paas et al. (1996) were used.the KA-binding residues, except for Y73, is involved in
All binding curves were carried out at least twice with each con-CNQX binding, and because no other residues are in
centration points in triplicates. Displacement curves were fitted to
suitable proximity, we suggest that CNQX docks on KBP the equation Y 5 1 2 {[L]n/([L]n 1 [IC50]n)} where Y is the fractional
in the vicinity of Y36 and F342. The direct interaction of occupancy; [L], the concentration of the unlabeled ligand; IC50, the
these residues with CNQX could not be evaluated, since concentration of the unlabeled ligand inhibiting 50% of [3H]KA bind-
the Y36I and F342I mutants displayed no [3H]KA binding ing; and n being the slope factor. When a small fraction of the
total ligand input (labeled and unlabeled) is bound, the free ligandactivity, in line with their predicted role in stabilization
concentration (total minus bound) is approximately equal to [L] andof the ligand-binding pocket structure. One has also to
the value of the slope factor (around the IC50) represents the Hillkeep in mind that CNQX may interact in part with the
coefficient (nH). Generally, [3H]KA was added at concentrations ofprotein backbone. 50 up to 150 nM, and 0.5%–2.5% of the [3H]KA input was observed
Y73 seems to plays a crucial role in ligand recognition, as bound. The calculations of the [3H]KA input concentration and
as it is the only residue that interacts with KA, Glu, that of bound [3H]KA were based on the specific radioactivity and
CNQX, as well as with guanine nucleotides (Paas et al., decomposition rates of [3H]KA stated by the manufacturer. Values
of the apparent dissociation constants for inhibition, Kiapp, were1996). This residue is present in a consensus nucleotide
calculated from the equation: (Kiapp)n 5 [IC50]n/{2([I0]/[I1])n 2 1 1 ([I1]/binding address highly conserved throughout the iono-
Kiapp(KA))n} used for the case of n interacting binding sites. In the casetropic Glu receptor subunits that, unlike the bacterial
of [3H]KA displacement by KA, the equation used was (Kiapp)n 5 [IC50]nPBPs, specifically recognize guanine derivatives in a
2 [I1]/2([I0]/[I1])n 2 1, where n is the Hill coefficient and I0 and I1 arecompetitive manner (Paas et al., 1996, and its refer- the free [3H]KA concentrations in the absence and presence of the
ences). This nucleotide binding address adopts a con- displacer, respectively. The values for the Gibbs free energy of bind-
formation in which the side chain of Y73 points inward ing (DG8) were derived from the equation: DG8 5 2RT lnKiapp where
into the interlobe cleft and allows its involvement in the gas constant R 5 1.987 calories 3 degree21 3 mole21 and T 5
277.18 degrees for binding reactions performedat 48C. The energiesligand binding. As a correlate, K72, which also plays a
of subunit interactions (DG8H) were calculated as described in therole in GTP binding (Paas et al., 1996), points away
footnotes for Table 3 and within the text.from the glutamatergic binding pocket in line with the
observation that the K72A/T mutants bind KA as effi-
Preparation of Anti-KBP Antibodies and Blotting Procedure
ciently as WT KBP (Table 1). Computer simulation of the KBP was purified as described by Gregor et al. (1988) and injected
respective docking of KA, Glu, and CNQX in the KBP in complete Freund’s adjuvant to rabbits. The anti-KBP antibodies
hybrid model structure clearly demonstrates that the were affinity purified as described by Beall and Mitchell (1986).
three ligands occupy overlapping space within the Following electrophoresis on SDS–polyacrylamide 8% slab gels, the
membranous proteins were blotted to nitrocellulose paper (BA85,ligand-binding pocket, in agreement with their competi-
Schleicher and Schuell, Federal Republic of Germany) as describedtive relationships.
by Towbin et al. (1979). Detection of the immunoreactive bandsThe KBP model structure elaborated from this work
was performed by using HRP-conjugated antibodies and the ECLcan now hopefully serve as a template for other Glu
detection reagents (Amersham International, England).
receptors. One can expect, however, that the coordi-
nates of model structuresof theother receptors will have Alignments and Computer-Assisted Molecular Modeling
to be adjusted in accordance with the varying nature of The building of the model structure was based on the assumption
the amino acid side chains that line the respective that KBP is structurally related to the PBPs. The programs FASTA
(Pearson and Lipman, 1988), BLAST (Altschul et al., 1990), and theligand-binding pocket so as to account for the diversity
Smith–Waterman algorithms (Smith and Waterman, 1981) were usedin the ligand binding specificities and affinities displayed
to align separately the S1 and S2 segments of KBP (see Figure 4Aby the various subtypes of Glu receptor/channels. At
for definition and amino acid numbering) with the sequences ofthis stage, the KBP model structure was already used
various PBPs, including arginine-binding protein, QBP, histidine-
as a template for building a model of GluR1, but adjust- binding protein, LAOBP, octopine-binding protein, nopaline-binding
ments are needed to account for the fact that mutations protein, and PhosBP. The three programs similarly aligned S1 with
that decrease KA binding to KBP affect the Glu and Quis the sequences of lobe I plus the first hinge and first b strand of lobe
but not the KA-induced responses of GluR1 (Mano et II in LAOBP. The resulting sequence alignments were also in general
agreement with the alignment proposed by O’Hara et al. (1993), butal., 1996).
with one significant deviation. The sequence G69–G80 instead of
W82–Q92 is the insert having no corresponding sequence in LAOBPExperimental Procedures
and other PBPs, in agreement with Nakanishi et al. (1990) and Cock-
croft et al. (1993).Chemicals
In contrast, most of the S2 segment did not show a significant[Vinylidene–3H]kainic acid (58 Ci/mmol) was purchased from New En-
amino acid sequence similarity with any PBP, in agreement withgland Nuclear (Boston, MA). Unless stated otherwise, other chemicals
Nakanishi et al. (1990). A consensus is reached only for a shortwere purchased from Sigma Chemical Company (St. Louis, MO).
sequence located at the carboxy-terminal portion of S2 (residues
341–377), which could be aligned with the carboxy-terminal se-Preparation of KBP Mutants
quence of the PBPs and which forms part of lobe I.KBP cDNA was subcloned in pMT3 expression vector (a gift from
the Genetics Institute, Cambridge, MA) (Swick et al., 1992) between The secondary structure predictions for the S91 and S92 segments
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(see Figure 4A for definition and amino acid numbering) performed
Received July 29, 1996; revised September 16, 1996.using the program PHD (Rost and Sander, 1994) showed that most
of the helices, b strands, and loops were correctly identified and
matched the LAOBP template. However, significant mismatches References
were found at two positions: the segment G69–N81 (in lobe I) was
predicted to be a loop, whereas residues W82–Q92 were predicted Altschul, S.F., Gish, W., Miller, W., Myers, E.W., and Lipman, D.J.
to form an a helix, in agreement with our sequence alignment with (1990). Basic local alignment search tool. J. Mol. Biol. 215, 403–410.
LAOBP. Since part of the G69–N81 loop (i.e., 69GDGKYG74) is a gua-
Ames, G.F.-L. (1986). Bacterial periplasmic transport system: struc-nine nucleotide–binding motif in GluRs (Paas et al., 1996), its struc-
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276–297 (in lobe II). Residues 276–294 were predicted on the basis 217–223.
of LAOBP to form a loop–b strand–loop structure, while residues Bennett, J.A., and Dingledine, R. (1995). Topology profile for a gluta-
295–297 are part of the following a helix. However, 11 amino acids mate receptor: three transmembrane domains and a channel-lining
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